Follow The Filings

XYL Xylem

Industrials, filed as XYLEM INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.0%
  • $1.8M
  • 1 add

In 2026 Q2 Mairs & Power added to Xylem.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Mairs & Power). Not free-float ownership.

  1. Mairs & Power Add 0.02%

Who owns XYL

Sorted by value, long equity only, as of 2026 Q2.

History
Mairs & Power 0.02% Add +9.7% 15,450 $1.8M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by XYL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All XYL insider trades
  • $1.1M bought by 2 insiders
  • $2.3M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. D Christian Koch Director
    Buy
    $986K 11,000 shares at $89.60 +882% to stake
    Traded Oct 29 Filed Oct 29
    ↗
  2. Geri-Michelle McShane SVP, CAO
    Sale
    $501K 4,269 shares at $117.46 54% of stake
    Traded May 7 Filed May 8
    ↗
  3. Jerome A Peribere Director
    Buy
    $141K 1,210 shares at $116.61 +4.7% to stake
    Traded May 4 Filed May 4
    ↗
  4. Victoria D Harker Director
    Sale
    $252K 1,700 shares at $148.14 9.2% of stake
    Traded Nov 4, 2025 Filed Nov 5, 2025
    ↗
  5. Claudia S Toussaint EVP, Cpso
    Sale
    $1.6M 10,421 shares at $152.64 25% of stake
    Traded Oct 30, 2025 Filed Oct 31, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 49 stock grants, 34 share withholdings for taxes, and 1 option exercise.

Congress

No member of Congress reported trading XYL in the last three years. 3 members listed it in 2025 annual reports.

All Congress trades

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,5.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
8-K 1.01,1.02,2.03,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.03,8.01,9.01 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated about 17 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $7.36B $8.56B $9.04B
Gross profit $2.72B $3.21B $3.48B
Gross margin * 36.9% 37.5% 38.5%
Net income $609M $890M $957M
Net margin * 8.3% 10.4% 10.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $3.88B $4.1B $4.64B
Total non-current assets * $12.23B $12.4B $12.99B
Total assets $16.11B $16.49B $17.63B
Total current liabilities $2.2B $2.34B $2.86B
Total non-current liabilities * $3.73B $3.28B $3.03B
Total equity $10.17B $10.64B $11.48B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $0.837B $1.26B $1.24B
Cash from investing -$628M -$482M -$471M
Cash from financing -$157M -$615M -$501M
Net change in cash $75M $102M $358M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.